hD

Income Statement Summary

Heska (HSKA) annual income statement covering fiscal 2017 through 2022, as reported to the SEC.

  • Heska reported revenue of $257.31M in fiscal 2022, up 1.4% from $253.74M in fiscal 2021.
  • Gross profit was $111.17M, up 5.1% from $105.79M. That is a gross margin of 43.2%.
  • Operating loss was $20.3M, a bigger loss than the $993K in fiscal 2021. Operating margin was -7.9%.
  • Net loss was $19.89M, a bigger loss than the $1.15M in fiscal 2021. Net margin was -7.7%.
  • Diluted earnings per share was -$1.92, a bigger loss than the $0.11 in fiscal 2021.
  • Cost of revenue took 56.8% of revenue, research and development 7.7% and general and administrative 24.9%.

Revenue has grown 14.7% a year on average since fiscal 2017, from $129.34M to $257.31M.

An income statement shows what a company sold and what it cost to run the business, ending with the profit left over.

Figures in USD thousands, except per share data
Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Revenues [Abstract]
Revenue, net

257,307

253,739

197,323

122,661

127,446

129,341

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Revenue, net

257,307

253,739

197,323

122,661

127,446

129,341

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Cost of revenue

146,140

147,945

116,033

68,212

70,808

71,080

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Cost of revenue

146,140

147,945

116,033

68,212

70,808

71,080

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Gross profit

111,167

105,794

81,290

54,449

56,638

58,261

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Gross profit

111,167

105,794

81,290

54,449

56,638

58,261

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating expenses:
Selling and marketing

47,661

45,284

38,468

27,678

24,663

23,225

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Selling and marketing

47,661

45,284

38,468

27,678

24,663

23,225

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Research and development

19,753

6,982

8,772

8,240

3,334

2,004

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Research and development

19,753

6,982

8,772

8,240

3,334

2,004

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

General and administrative

64,051

54,521

42,242

18,204

24,847

14,813

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

General and administrative

64,051

54,521

42,242

18,204

24,847

14,813

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total operating expenses

131,465

106,787

89,482

54,122

52,844

40,042

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total operating expenses

131,465

106,787

89,482

54,122

52,844

40,042

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating loss

-20,298

-993

-8,192

327

3,794

18,219

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating loss

-20,298

-993

-8,192

327

3,794

18,219

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Interest and other (income) expense, net

1,536

2,448

5,601

2,910

-13

-150

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Interest and other (income) expense, net

1,536

2,448

5,601

2,910

-13

-150

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss before taxes and equity in losses of unconsolidated affiliates

-21,834

-3,441

-13,793

-2,583

3,807

18,369

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss before taxes and equity in losses of unconsolidated affiliates

-21,834

-3,441

-13,793

-2,583

3,807

18,369

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Income tax (benefit) expense:
Current income tax expense

1,300

900

1,800

400

100

49

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Current income tax expense

1,300

900

1,800

400

100

49

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Deferred income tax benefit

-4,698

-4,464

-1,541

-1,805

-2,255

8,864

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Deferred income tax benefit

-4,698

-4,464

-1,541

-1,805

-2,255

8,864

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total income tax benefit

-3,400

-3,600

200

-1,400

-2,100

8,913

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total income tax benefit

-3,400

-3,600

200

-1,400

-2,100

8,913

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net (loss) income before equity in losses of unconsolidated affiliates

-18,424

132

-14,032

-1,137

5,922

9,456

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net (loss) income before equity in losses of unconsolidated affiliates

-18,424

132

-14,032

-1,137

5,922

9,456

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Equity in losses of unconsolidated affiliates

-1,465

-1,280

-720

-594

-72

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Equity in losses of unconsolidated affiliates

-1,465

-1,280

-720

-594

-72

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss after equity in losses of unconsolidated affiliates

-19,889

-1,148

-14,752

-1,731

5,850

9,456

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss after equity in losses of unconsolidated affiliates

-19,889

-1,148

-14,752

-1,731

5,850

9,456

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss attributable to redeemable non-controlling interest

-

-

-353

-266

-

-497

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss attributable to redeemable non-controlling interest

-

-

-353

-266

-

-497

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss attributable to Heska Corporation

-19,889

-1,148

-14,399

-1,465

5,850

9,953

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Net loss attributable to Heska Corporation

-19,889

-1,148

-14,399

-1,465

5,850

9,953

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Earnings Per Share [Abstract]
Basic (loss) earnings per share attributable to Heska Corporation (in dollars per share)

-1.92

-0.11

-1.66

-0.20

0.81

1.42

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Basic (loss) earnings per share attributable to Heska Corporation (in dollars per share)

-1.92

-0.11

-1.66

-0.20

0.81

1.42

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Diluted (loss) earnings per share attributable to Heska Corporation (in dollars per share)

-1.92

-0.11

-1.66

-0.20

0.74

1.30

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Diluted (loss) earnings per share attributable to Heska Corporation (in dollars per share)

-1.92

-0.11

-1.66

-0.20

0.74

1.30

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation (in shares)

10,343

10,015

8,653

7,446

7,220

7,026

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Weighted average outstanding shares used to compute basic (loss) earnings per share attributable to Heska Corporation (in shares)

10,343

10,015

8,653

7,446

7,220

7,026

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation (in shares)

10,343

10,015

8,653

7,446

7,856

7,642

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Weighted average outstanding shares used to compute diluted (loss) earnings per share attributable to Heska Corporation (in shares)

10,343

10,015

8,653

7,446

7,856

7,642

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Core companion animal
Total revenue, net

-

-

-

-

-

105,191

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total revenue, net

-

-

-

-

-

105,191

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Other vaccines and pharmaceuticals
Total revenue, net

-

-

-

-

-

24,150

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total revenue, net

-

-

-

-

-

24,150

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx